These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 12435727)
1. Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. Andl CD; Mizushima T; Nakagawa H; Oyama K; Harada H; Chruma K; Herlyn M; Rustgi AK J Biol Chem; 2003 Jan; 278(3):1824-30. PubMed ID: 12435727 [TBL] [Abstract][Full Text] [Related]
2. EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes. Andl CD; Mizushima T; Oyama K; Bowser M; Nakagawa H; Rustgi AK Am J Physiol Gastrointest Liver Physiol; 2004 Dec; 287(6):G1227-37. PubMed ID: 15284024 [TBL] [Abstract][Full Text] [Related]
3. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion. Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194 [TBL] [Abstract][Full Text] [Related]
4. AKT induces senescence in primary esophageal epithelial cells but is permissive for differentiation as revealed in organotypic culture. Oyama K; Okawa T; Nakagawa H; Takaoka M; Andl CD; Kim SH; Klein-Szanto A; Diehl JA; Herlyn M; El-Deiry W; Rustgi AK Oncogene; 2007 Apr; 26(16):2353-64. PubMed ID: 17043653 [TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3. Takaoka M; Harada H; Andl CD; Oyama K; Naomoto Y; Dempsey KL; Klein-Szanto AJ; El-Deiry WS; Grimberg A; Nakagawa H Cancer Res; 2004 Nov; 64(21):7711-23. PubMed ID: 15520175 [TBL] [Abstract][Full Text] [Related]
6. Coordinated functions of E-cadherin and transforming growth factor beta receptor II in vitro and in vivo. Andl CD; Fargnoli BB; Okawa T; Bowser M; Takaoka M; Nakagawa H; Klein-Szanto A; Hua X; Herlyn M; Rustgi AK Cancer Res; 2006 Oct; 66(20):9878-85. PubMed ID: 17047049 [TBL] [Abstract][Full Text] [Related]
7. The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. Okawa T; Michaylira CZ; Kalabis J; Stairs DB; Nakagawa H; Andl CD; Johnstone CN; Klein-Szanto AJ; El-Deiry WS; Cukierman E; Herlyn M; Rustgi AK Genes Dev; 2007 Nov; 21(21):2788-803. PubMed ID: 17974918 [TBL] [Abstract][Full Text] [Related]
8. SMAD7 in keratinocytes promotes skin carcinogenesis by activating ATM-dependent DNA repair and an EGFR-mediated cell proliferation pathway. Ha Thi HT; Kim HY; Lee YJ; Kim SJ; Hong S Carcinogenesis; 2019 Mar; 40(1):112-120. PubMed ID: 30219864 [TBL] [Abstract][Full Text] [Related]
10. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR. Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. Buchanan FG; Wang D; Bargiacchi F; DuBois RN J Biol Chem; 2003 Sep; 278(37):35451-7. PubMed ID: 12824187 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. Chen P; Xie H; Sekar MC; Gupta K; Wells A J Cell Biol; 1994 Nov; 127(3):847-57. PubMed ID: 7962064 [TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt. Han C; Wu T J Biol Chem; 2005 Jun; 280(25):24053-63. PubMed ID: 15855163 [TBL] [Abstract][Full Text] [Related]
14. Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras. Dlugosz AA; Hansen L; Cheng C; Alexander N; Denning MF; Threadgill DW; Magnuson T; Coffey RJ; Yuspa SH Cancer Res; 1997 Aug; 57(15):3180-8. PubMed ID: 9242447 [TBL] [Abstract][Full Text] [Related]
15. EGF-mediated regulation of IGFBP-3 determines esophageal epithelial cellular response to IGF-I. Takaoka M; Smith CE; Mashiba MK; Okawa T; Andl CD; El-Deiry WS; Nakagawa H Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G404-16. PubMed ID: 16210470 [TBL] [Abstract][Full Text] [Related]
17. Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa). Barnes CJ; Bagheri-Yarmand R; Mandal M; Yang Z; Clayman GL; Hong WK; Kumar R Mol Cancer Ther; 2003 Apr; 2(4):345-51. PubMed ID: 12700278 [TBL] [Abstract][Full Text] [Related]
18. Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C delta. Denning MF; Dlugosz AA; Threadgill DW; Magnuson T; Yuspa SH J Biol Chem; 1996 Mar; 271(10):5325-31. PubMed ID: 8621384 [TBL] [Abstract][Full Text] [Related]
19. Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells. Yoshioka M; Ohashi S; Ida T; Nakai Y; Kikuchi O; Amanuma Y; Matsubara J; Yamada A; Miyamoto S; Natsuizaka M; Nakagawa H; Chiba T; Seno H; Muto M J Exp Clin Cancer Res; 2017 Aug; 36(1):101. PubMed ID: 28764725 [TBL] [Abstract][Full Text] [Related]